Method of inducing and differentiating human umbilical cord derived mesenchymal stem cells into cartilage cells
A technology of mesenchymal stem cells and induced differentiation, applied in the field of induced differentiation of stem cells, can solve the problems of latent virus and pathogenic microorganism infection and low probability of transmission
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Publication Date
- 2017-05-10
- Estimated Expiration
- Not applicable · inactive patent
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to a method for inducing differentiation of stem cells, in particular to a method for inducing the differentiation of human umbilical cord-derived mesenchymal stem cells into chondrocytes. Background technique
[0002] Knee cartilage injury is one of the main research fields of sports medicine clinical work, and it is a hot spot and focus of sports science research. In the early stage of articular cartilage damage, it can cause pain and limitation of joint function of the injured joint. In the late stage, the joint may have degeneration and non-inflammatory osteoarthritis, which will seriously reduce the quality of life of the patient. After articular cartilage is damaged, chondrocytes mainly rely on synovial fluid and the matrix around the cells to provide nutrition, and supply energy through anaerobic glycolysis. Their own repair ability is very limited, and they cannot even be repaired by themselves.
[0003] The emergence of ...
Examples
Embodiment Construction
[0030] The method of the present invention for inducing differentiation of human umbilical cord-derived mesenchymal stem cells into chondrocytes is to clean the umbilical cord tissue to remove blood stains and cut it into small sections, cut open the small section of umbilical cord to remove vascular tissue, cut up the small section of umbilical cord and digest it to obtain a single mesenchymal stem cell, The obtained mesenchymal stem cells were amplified and cultured to the seventh passage to obtain a single cell suspension, inoculated in serum-free medium containing chondrogenic differentiation inducer to continue culturing, half of the fresh medium was replaced every 3 days, and after 14 days of induction , to obtain chondrocytes.
[0031] Specifically, the preparation of the single-cell suspension is carried out first (1) pretreatment of the umbilical cord tissue, followed by (2) enzyme digestion method to obtain primary MSCs cells from the umbilical cord, and then (3) umbi...